These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30157220)

  • 1. Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice.
    O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
    PLoS One; 2018; 13(8):e0202350. PubMed ID: 30157220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db/db mice.
    O'Harte FPM; Parthsarathy V; Flatt PR
    Mol Cell Endocrinol; 2020 Mar; 504():110695. PubMed ID: 31904406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties.
    O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
    Biochem Pharmacol; 2017 Dec; 146():165-173. PubMed ID: 28987595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
    Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes.
    Vasu S; Ojo OO; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YHA
    Amino Acids; 2017 Oct; 49(10):1705-1717. PubMed ID: 28836148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial actions of a long-acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation.
    Tanday N; Irwin N; Moffett RC; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2020 Dec; 22(12):2468-2478. PubMed ID: 32844576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions.
    O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
    Peptides; 2018 Feb; 100():219-228. PubMed ID: 29412822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
    Srinivasan DK; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH
    Acta Diabetol; 2016 Apr; 53(2):303-15. PubMed ID: 26138324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
    O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
    Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
    Porter WD; Flatt PR; Hölscher C; Gault VA
    Int J Obes (Lond); 2013 May; 37(5):678-84. PubMed ID: 22665137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice.
    O'Harte FP; Franklin ZJ; Irwin N
    Diabetes Obes Metab; 2014 Dec; 16(12):1214-22. PubMed ID: 25060150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
    Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
    Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
    Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
    Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice.
    Pathak V; Gault VA; Flatt PR; Irwin N
    Mol Cell Endocrinol; 2015 Feb; 401():120-9. PubMed ID: 25449420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization.
    Take K; Mochida T; Maki T; Satomi Y; Hirayama M; Nakakariya M; Amano N; Adachi R; Sato K; Kitazaki T; Takekawa S
    PLoS One; 2016; 11(3):e0150976. PubMed ID: 26938273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable oxyntomodulin analogues exert positive effects on hippocampal neurogenesis and gene expression as well as improving glucose homeostasis in high fat fed mice.
    Pathak NM; Pathak V; Lynch AM; Irwin N; Gault VA; Flatt PR
    Mol Cell Endocrinol; 2015 Sep; 412():95-103. PubMed ID: 26048772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triphala and its constituents ameliorate visceral adiposity from a high-fat diet in mice with diet-induced obesity.
    Gurjar S; Pal A; Kapur S
    Altern Ther Health Med; 2012; 18(6):38-45. PubMed ID: 23251942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
    Irwin N; Montgomery IA; Moffett RC; Flatt PR
    Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.